相关实验视频
Updated: Sep 17, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.9K
血清炎症因子水平变化与慢性阻塞性肺病患者的疾病严重程度之间的相关性 结核复杂的慢性阻塞性肺病患者
Yiyao Di1, Fan Yang2, Conglu Che3
1Respiratory Department, Affiliated Hospital of Hebei University, Baoding, Hebei, People's Republic of China.
International journal of general medicine
|July 3, 2025
概括
血清炎症标志物如TNF-α和IL-6的升高可能表明慢性阻塞性肺病 (COPD) 和结核病 (TB) 患者的结果更差. 这些发现表明,在这种复杂的并发症中,评估疾病严重程度和预后的潜在生物标志物.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 和结核病 (TB) 经常同时存在,这给诊断和治疗带来了挑战.
- 这种双重并发症显著增加了疾病负担和死亡率.
- 血清炎症因子和结核病COPD患者的临床过程之间的关系尚不清楚.
研究的目的:
- 研究血清炎症标志物与COPD和结核病患者的疾病严重程度和预后之间的相关性.
- 为了比较COPD和结核病患者的炎症标志物水平,与单独患有COPD和结核病患者和健康对照者进行比较.
主要方法:
- 一项涉及200名参与者的回顾性研究:80名患有COPD和结核病,40名仅患有COPD,40名仅患有结核病和40名健康对照.
- 测量了瘤亡因子-α (TNF-α),介素-6 (IL-6),干扰素-γ (IFN-γ),可溶性IL-2受体 (sIL-2R) 和C反应蛋白 (CRP) 的血清水平.
- 统计分析比较了不同组的标志物水平,并将它们与结核病队列中的COPD疾病严重程度和预后相关联.
主要成果:
- 与所有其他组相比,COPD和结核病患者的TNF-α,IL-6,IFN-γ,sIL-2R和CRP的血清水平显着更高.
- 在结核病的COPD组中,这些炎症标志物的水平升高与疾病严重程度的增加有关.
- 较高的炎症标志物水平与COPD和结核病同时存在的患者的预后较差相关.
结论:
- 血清炎症标志物可以作为评估COPD和结核病患者疾病严重程度和预后的潜在指标.
- 该研究的观察性质排除了明确的因果推断.
- 需要进一步的前性多中心研究来验证这些发现的临床应用.
更多相关视频
相关概念视频
Pulmonary Tuberculosis IV
207
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
207
Pulmonary Tuberculosis III
451
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
451
Pulmonary Tuberculosis II
379
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
379
Pulmonary Tuberculosis I
331
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
331
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Pulmonary Tuberculosis V
243
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
243

